Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMS201 in Ureteroscopic Stone Removal
NCT00857090Phase 2Completed
- Sponsor
- Omeros Corporation
- Start
- Mar 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketoprofen, nifedipine in urolithiasis, sponsored by Omeros Corporation. Started Mar 2009; status: completed.
02
Drugs
ketoprofennifedipine
03
Conditions
urolithiasis
Beyond the preview
Go deeper on NCT00857090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00857090.